The Delhi High Court has delivered a sharp reminder that public health regulation is not a waiting game for damage to be done. In a ruling with wide implications for drug safety oversight, the Court ...

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--EX US, UK and UAE Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced results of a 24-week open label arm ...

"I think these are very interesting findings, even if the study wasn't powered for cardiovascular end points," said lead investigator Dr Baptist Gallwitz (Eberhard-Karls-University Tübingen, Germany).

(HealthDay)—Linagliptin is noninferior to glimepiride for adults with relatively early type 2 diabetes and elevated cardiovascular risk, according to a study published online Sept. 19 in the Journal ...

The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus. In an early benefit ...